TNDM TANDEM DIABETES CARE
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 27 analyst firms say about TANDEM DIABETES CARE: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
24 rated views · 27 analyst/firm records · 27 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8044
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8041
Recent analyst activity · last 90 days
Our tracked history has 6 reports on TNDM from 6 analyst firms in the last 90 days (28 firms in the past year).
Comparing each firm's latest target with its previous one: 3 lowered it and 1 left it unchanged.
Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.
Latest observed target change: Mizuho lowered its target from $22.00 (set 20 Feb 2026) to $18.00 on 13 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Jeffrey D Johnson | Buy | 22 May 2026 | 30.00 USD |
| Bank of America Securities | Travis Steed | Hold | 18 May 2026 | 25.00 USD |
| Barclays | Christopher Pasquale | Hold | 7 Oct 2026 | 18.00 USD |
| Benchmark | Bruce Jackson | Hold | 11 May 2026 | — |
| Bernstein | Lee Hambright | Hold | 1 Jun 2026 | 25.00 USD |
| Canaccord Genuity | William Plovanic | — | 7 Aug 2026 | 40.00 USD |
| CFRA | Kenneth Leon | Hold | 1 Jun 2026 | 22.00 USD |
| Citigroup | Joanne Wuensch | Hold | 30 Sep 2026 | 20.00 USD |
| Deutsche Bank | Kieran Ryan | Hold | 23 Jun 2026 | 15.50 USD |
| Goldman Sachs | David H Roman | Hold | 14 Jul 2026 | 16.00 USD |
| Jefferies | Matthew C Taylor | Buy | 1 Jul 2026 | 48.00 USD |
| Lake Street Capital Markets | Frank Takkinen | Buy | 7 Aug 2026 | 50.00 USD |
| Leerink Partners | Michael Kratky | Buy | 6 Aug 2026 | 27.00 USD |
| Mizuho | Anthony Petrone | — | 13 Oct 2026 | 18.00 USD |
| Oppenheimer | Unnamed analyst | Buy | 7 Aug 2026 | — |
| Piper Sandler | Matthew O'Brien | Buy | 6 Aug 2026 | 33.00 USD |
| RBC Capital Markets | Kendall Au | Buy | 7 Aug 2026 | 26.00 USD |
| Redburn | Issie Kirby | Buy | 7 Aug 2026 | 40.00 USD |
| Stifel | Jonathan Block | Hold | 20 Feb 2026 | 22.00 USD |
| TD Cowen | Mathew Blackman | Buy | 20 Apr 2026 | 28.00 USD |
| Truist | Richard Newitter | Buy | 24 Sep 2026 | 28.00 USD |
| UBS | Patrick Wood | Hold | 28 Jul 2026 | 18.00 USD |
| Weiss Ratings | Unnamed analyst | — | 8 Sep 2026 | — |
| Wells Fargo | Lawrence Biegelsen | Buy | 1 Jun 2026 | 27.00 USD |
| William Blair | Steven Lichtman | Buy | 21 Aug 2026 | — |
| Wolfe Research | Mike Polark | Hold | 1 Apr 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 10 Jun 2026 | Conflicting reports · excluded |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:01 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.